Clinical Research Institute of Southern Oregon, PC

Medford, Oregon OR 97504

0 studies enrolling now · 33 studies all time

What they study most

Albuminuria, Allergic Rhinitis Due to Grass Pollens, Asthma, Atopic Dermatitis, COPD, Chronic Bronchitis, Chronic Obstructive Pulmonary Disease, Chronic Obstructive Pulmonary Disease (COPD), Diabetes Mellitus, Type 2, Diabetic Nephropathy, Emphysema, Hyperlipidemia

Studies at this site

• A Study of an Adenovirus Serotype 26 Pre-fusion Conformation-stabilized F Protein (Ad26. RSV. preF) Based Respiratory Syncytial Virus (RSV) Vaccine in the Prevention of Lower Respiratory Tract Disease in Adults Aged 60 Years and Older — Completed
• A Study of Ad26.COV2.S for the Prevention of SARS-CoV-2-Mediated COVID-19 in Adult Participants — Completed
• Efficacy, Safety, and Pharmacokinetic Profile of Etokimab (ANB020) in Adult Participants With Moderate-to-Severe Atopic Dermatitis — Completed
• Randomized, Placebo-controlled, Multi-dose, Study Comparing Budesonide/Formoterol to Symbicort® in Asthmatic Patients — Completed
• Evaluation of Two Doses of QVAR by Breath Operated and Metered Dose Inhalers in Asthmatic Children — Completed
• A Study to Evaluate the Safety and Efficacy of JNJ-64565111 in Severely Obese Participants With Type 2 Diabetes Mellitus — Completed
• Safety and Efficacy Study of Treatment With Single Doses of CHF 4226 pMDI in Patients With Chronic Obstructive Pulmonary Disease (COPD) — Completed
• Comparison of Efficacy, Safety, and Tolerability of ITCA 650 to Empagliflozin and Glimepiride as add-on Metformin — Stopped early
• Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events — Completed
• A Dose-Range Finding Study of SUN-101 in Subjects With Moderate to Severe COPD — Completed
• Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD — Completed
• A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD — Completed
• A Study of the Efficacy and Safety of EP-101 ( (SUN101) in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease — Completed
• Study to Evaluate the Efficacy, Safety and Pharmacokinetics of PT001, PT003, and PT005 Following Chronic Dosing (7 Days) in Patients With Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) — Completed
• Dose Finding Study of CHF 4226 for Treating Patients With COPD — Completed
• Study of Efficacy and Safety of 300 IR Sublingual Immunotherapy (SLIT) Tablets in Adult Patients With Allergic Grass Pollen Rhinoconjunctivitis — Completed
• A Study to Evaluate the Safety and Tolerability of a Nasal Spray to Treat Perennial Allergic Rhinitis — Completed
• A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Seasonal Allergic Rhinitis (SAR) — Completed
• A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Perennial Allergic Rhinitis (PAR). — Completed
• Safety Study of Arformoterol Tartrate Inhalation Solution in Chronic Obstructive Pulmonary Disease (COPD) Subjects — Completed
• TC-6987 for the Treatment of Mild to Moderate Asthma — Completed
• A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies — Completed
• Study To Evaluate Patient Preference, Satisfaction And Efficacy Of a Nasal Aerosol Versus an Aqueous Nasal Spray — Completed
• To Evaluate the Long-term Safety of (R,R)-Formoterol in Subjects With COPD — Completed
• 26 Week Efficacy, Safety and Tolerability Study of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD) — Completed
• A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Perennial Allergies — Completed
• Open Label Study to Assess Safety and Immunogenicity of Omalizumab Liquid Formulation. — Completed
• Confirmatory Dose Finding Study of 2 Dosages of CHF 4226 pMDI (Carmoterol) in Patients With COPD — Completed
• Induction of Immunogenicity With Different Doses of TreeMATA in Subjects Allergic to Tree Pollen — Completed
• Induction of Immunogenicity With Different Doses of Grass MATA in Subjects Allergic to Grass and Rye Pollen — Completed
• Study of XL784 in Patients With Albuminuria Due to Diabetic Nephropathy — Completed
• Effects of PN2034 in Insulin-Dependent Patients With Type 2 Diabetes — Completed
• Safety and Efficacy Study of PN2034 in Type 2 Diabetes Patients on Concomitant Rosiglitazone and Metformin (or Avandamet) — Completed